Vasularized Micro-Tumor Platform
CompanyAracari Biosciences, Irvine, USA
In Aracari’s platforms, self-assembled human blood vessels support tissue growth by delivering nutrients and drugs and cell therapies. The Vascularized Micro-Tumor platform is suitable for testing lead compound efficacy in inhibiting tumors growing in a biomimetic environment. Comprised of endothelial and stromal cells, the platform also includes human colon cancer, lung cancer or customized tumors of interest. Further oncology services include delivery of therapeutics to tumors via blood vessels, and measurement of tumor growth inhibition or tumor occupancy (T cells, oncolytic virus etc.). Immuno-oncology services are leukocyte vessel adhesion & extravasation, parallel delivery of leukocytes and immuno-oncological therapies (e.g. monoclonal antibodies), tumor occupancy by T cells (including CAR-Ts) or cytokine expression.
Vascularized Micro-Tumor (VMT™)
info@aracaribio.com
Added on: 12-19-2022
[1] https://aracaribio.com/technology/#vmt
